We are live on
!
Find out more
JG
Jain Global Portfolio holdings
AUM
$24.2B
1-Year Est. Return
34.82%
This Fund
S&P 500
This Quarter
Est. Return
+11.86%
1 Year Est. Return
+34.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.9B
AUM Growth
+$4.5B
(+54%)
Cap. Flow
+$3.27B
Cap. Flow
% of AUM
25.4%
Top 10 Holdings %
Top 10 Hldgs %
34.34%
Holding
1,700
New
646
Increased
290
Reduced
172
Closed
568
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$74.9M |
| 3 |
American Tower
AMT
|
+$74.5M |
| 4 |
Ecolab
ECL
|
+$71.2M |
| 5 |
Tesla
TSLA
|
+$69.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$64.2M |
| 3 |
NVIDIA
NVDA
|
+$58.5M |
| 4 |
PPG Industries
PPG
|
+$47.7M |
| 5 |
Boeing
BA
|
+$41.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.12% |
| 2 | Industrials | 6.77% |
| 3 | Consumer Discretionary | 5.95% |
| 4 | Financials | 5.42% |
| 5 | Healthcare | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Bumble
BMBL
$367M
| $87.8K | ﹤0.01% |
13,325
-91,796
| -87% | -$463K |
|
1027
Achieve Life Sciences
ACHV
$626M
| $87.7K | ﹤0.01% |
+38,806
| New | +$111K |
|
1028
Neumora Therapeutics
NMRA
$276M
| $86.9K | ﹤0.01% |
118,493
+65,106
| +122% | +$49.3K |
|
1029
Claros Mortgage Trust
CMTG
$306M
| $86K | ﹤0.01% |
+30,170
| New | +$80.9K |
|
1030
Cabaletta Bio
CABA
$439M
| $85.4K | ﹤0.01% |
+56,160
| New | +$87.6K |
|
1031
Corbus Pharmaceuticals
CRBP
$170M
| $85.3K | ﹤0.01% |
+12,369
| New | +$89.9K |
|
|
FLNA
1032
Filana Therapeutics
FLNA
$43M
| $84.8K | ﹤0.01% |
+46,842
| New | +$83.4K |
|
1033
Leslie's
LESL
$11.6M
| $84.4K | ﹤0.01% |
10,052
+6,572
| +189% | +$86.5K |
|
1034
QuickLogic
QUIK
$224M
| $84K | ﹤0.01% |
+13,642
| New | +$74.9K |
|
1035
Zentalis Pharmaceuticals
ZNTL
$308M
| $83.8K | ﹤0.01% |
+72,261
| New | +$95.3K |
|
1036
Skye Bioscience
SKYE
$22.9M
| $83K | ﹤0.01% |
+19,852
| New | +$41.1K |
|
|
ZYXI
1037
DELISTED
Zynex
ZYXI
| $80.7K | ﹤0.01% |
+31,295
| New | +$70.8K |
|
1038
Kyverna Therapeutics
KYTX
$450M
| $80.6K | ﹤0.01% |
+26,243
| New | +$64.9K |
|
|
EB
1039
DELISTED
Eventbrite
EB
| $80.1K | ﹤0.01% |
+30,458
| New | +$70.1K |
|
|
CTNM
1040
Contineum Therapeutics
CTNM
$526M
| $77.8K | ﹤0.01% |
+19,590
| New | +$85.1K |
|
1041
Veru
VERU
$36.1M
| $76.6K | ﹤0.01% |
+13,161
| New | +$73.9K |
|
1042
Inovio Pharmaceuticals
INO
$79.8M
| $76.5K | ﹤0.01% |
+37,601
| New | +$72.1K |
|
1043
The ONE Group
STKS
$57.1M
| $76.5K | ﹤0.01% |
+18,892
| New | +$65K |
|
1044
Commercial Vehicle Group
CVGI
$157M
| $76.5K | ﹤0.01% |
+46,070
| New | +$56K |
|
1045
Energy Vault
NRGV
$522M
| $75.8K | ﹤0.01% |
+105,706
| New | +$85.4K |
|
1046
Cardlytics
CDLX
$21M
| $75.5K | ﹤0.01% |
+4,590
| New | +$79.3K |
|
1047
Equinox Gold
EQX
$7.32B
| $74.8K | ﹤0.01% |
+13,000
| New | +$84.4K |
|
1048
VirTra
VTSI
$35.8M
| $72.4K | ﹤0.01% |
+10,240
| New | +$53.9K |
|
1049
MacroGenics
MGNX
$235M
| $71.8K | ﹤0.01% |
+59,339
| New | +$86.1K |
|
1050
Sabre
SABR
$656M
| $70.8K | ﹤0.01% |
+22,394
| New | +$57.4K |
|
Similar funds
SC
CS
Jain Global's Q2 2025 Portfolio in Review
As of Q2 2025, Jain Global held 1,700 positions worth $12.9B, up 54% from $8.39B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jain Global deployed $3.27B of net new capital in Q2 2025, opening 646 new positions and adding to 290 existing holdings. Its largest new stake was Brown & Brown: 997,801 shares worth $111M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $58.5M trimmed.
- Jain Global's largest Q2 2025 buy was Brown & Brown: 997,801 shares worth $111M.
- Jain Global added most to iShares MSCI Emerging Markets ETF in Q2 2025, an estimated $74.9M increase.
- Jain Global's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $58.5M.
- Jain Global fully exited iShares Core S&P 500 ETF in Q2 2025, selling an estimated $1.3B.
- Jain Global's ten largest holdings make up 34% of its $12.9B portfolio in Q2 2025.
- Jain Global opened 646 new positions and closed 568 in Q2 2025.
- Jain Global's portfolio value rose 54% quarter-over-quarter to $12.9B.
Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.